ByHeart has expanded its voluntary recall to include all Whole Nutrition Infant Formula cans and Anywhere Pack products amid an investigation by the Food and Drug Administration and other agencies of a multistate outbreak of infant botulism illnesses. The recall was previously limited to certain lots. As of Nov. 11, 15 infants had suspected or confirmed botulism and confirmed exposure to ByHeart Whole Nutrition infant formula, according to the FDA. Cases have been reported by 12 states.   
  
A company notice published by the FDA said that no unopened ByHeart product has tested positive for Clostridium botulinum spores or toxin, which can cause botulism. All products were proactively recalled to help the FDA and other investigators identify a root cause of the outbreak, which includes testing all batches of formula with an independent third-party laboratory. The FDA said it has been conducting a broader investigation with the Centers for Disease Control and Prevention into a recent spike of 84 infant botulism cases that began in August. The FDA recommended consumers with any ByHeart Whole Nutrition Infant Formula cans and Anywhere Pack products should discontinue use and dispose of them immediately. 

Headline
The Food and Drug Administration has issued an early alert for all heart pump controllers by Abiomed, which sent a correction notice to all customers with…
Headline
Elizabeth Mort, M.D., vice president and chief medical officer at Joint Commission, breaks down the five critical priorities boards must focus on — …
Blog
High-quality maternal care is essential to protecting the health of both mom and baby during birth.Sutter Health is taking a proactive, systemwide approach to…
Headline
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy…
Headline
USA Today published a column  by AHA Board Chair Marc Boom, M.D., president and CEO of Houston Methodist, highlighting how hospitals and health systems…
Headline
The Food and Drug Administration has identified a nationwide recall. Arrow International is recommending dialysis catheter kits containing Merit Medical 16F…